MARKET

CHSYF

CHSYF

China Medical
OTCPK
0.931
NaN%
Closed 09:30 05/12 EDT
OPEN
--
PREV CLOSE
0.931
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.931
52 WEEK LOW
0.931
MARKET CAP
2.27B
P/E (TTM)
10.18
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CHSYF last week (0505-0509)?
Weekly Report · 20h ago
Weekly Report: what happened at CHSYF last week (0428-0502)?
Weekly Report · 05/05 09:50
Weekly Report: what happened at CHSYF last week (0421-0425)?
Weekly Report · 04/28 09:54
China Medical System Holdings Reports Successful AGM Outcomes
TipRanks · 04/24 12:40
China Medical System Holdings Proposes Spin-Off and Listing of Dermavon
TipRanks · 04/22 13:38
Weekly Report: what happened at CHSYF last week (0414-0418)?
Weekly Report · 04/21 09:54
China Medical System Proposes Amendments to Modernize Operations
TipRanks · 04/17 12:44
Weekly Report: what happened at CHSYF last week (0407-0411)?
Weekly Report · 04/14 09:50
More
About CHSYF
China Medical System Holdings Ltd is an investment holding company principally engaged in the production of medicines, as well as marketing, promotion and sales of drugs. The Company's products include Plendil, Ursofalk, Augentropfen Stulln Mono Eye Drops, Hirudoid, Atopic Piel Series and Vmonalisa, among others. Its major marketed products cover the cardio-cerebrovascular, gastroenterology, ophthalmology, dermatology and medical aesthetic fields. The Company distributes its products within domestic market and to overseas markets.

Webull offers China Medical System Holdings Ltd stock information, including OTCPK: CHSYF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CHSYF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CHSYF stock methods without spending real money on the virtual paper trading platform.